Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 565.40 USD | +3.67% |
|
+9.92% | -2.91% |
| Market Cap | 13.04B 11.43B 10.56B 9.75B 18.49B 1,248B 18.86B 127B 49.31B 611B 48.95B 47.88B 2,120B | P/E 2026 * |
-81.1x | P/E 2027 * | 57.2x |
|---|---|---|---|---|---|
| Enterprise Value | 12.51B 10.97B 10.13B 9.36B 17.74B 1,198B 18.09B 122B 47.3B 586B 46.97B 45.94B 2,034B | EV / Sales 2026 * |
8.36x | EV / Sales 2027 * | 5.41x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +3.67% | ||
| 1 week | +9.92% | ||
| Current month | +5.30% | ||
| 1 month | +21.00% | ||
| 3 months | +8.78% | ||
| 6 months | +1.65% | ||
| Current year | -2.91% |
| 1 week | 522.06 |  | 566.68 |
| 1 month | 460.89 | | 566.68 |
| Current year | 416.21 | | 598.79 |
| 1 year | 286.44 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 07/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 10/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 20/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 30/06/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 10/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 26/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Free | Founder | 1,220 | 0.0053% | ||
| 06-16 | Free | Director | 1,085 | 0.0047% | ||
| 06-16 | Baker Bros. Advisors LP
| Free | Company | 4,880 | 0.0212% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.67% | +9.92% | +96.65% | +158.02% | 12.57B | |
| -1.53% | +0.78% | +72.33% | +129.70% | 57.72B | |
| -2.45% | -7.83% | +63.92% | +83.15% | 52.65B | |
| +3.27% | +8.91% | +21.21% | +486.76% | 24.46B | |
| -0.81% | -0.42% | -16.24% | -12.47% | 23.84B | |
| +4.71% | +4.02% | +44.02% | -1.84% | 19.28B | |
| -0.24% | +5.11% | +38.76% | -26.41% | 17.8B | |
| +2.34% | +12.50% | +224.02% | +380.99% | 17.29B | |
| -1.38% | +1.24% | +35.33% | - | 15.28B | |
| -1.70% | +3.98% | +28.96% | +190.57% | 14.35B | |
| Average | +0.59% | +5.95% | +60.90% | +154.27% | 25.52B | |
| Weighted average by Cap. | -0.11% | +3.46% | +59.76% | +142.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 1.31B 1.21B 1.12B 2.12B 143B 2.16B 14.56B 5.66B 70.07B 5.62B 5.49B 243B | 2.21B 1.93B 1.79B 1.65B 3.13B 211B 3.19B 21.48B 8.34B 103B 8.28B 8.1B 359B |
| Net income | -201M -176M -163M -150M -285M -19.25B -291M -1.96B -760M -9.42B -755M -738M -32.7B | 308M 270M 249M 230M 436M 29.46B 445M 3B 1.16B 14.42B 1.16B 1.13B 50.05B |
| Net Debt | -529M -464M -429M -396M -751M -50.67B -766M -5.15B -2B -24.8B -1.99B -1.94B -86.08B | -1.09B -960M -886M -819M -1.55B -105B -1.58B -10.66B -4.14B -51.29B -4.11B -4.02B -178B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | US$565.40 | +3.67% | 468,222 |
| 07/07/26 | US$545.36 | +3.00% | 318,420 |
| 06/07/26 | US$529.48 | +0.26% | 230,982 |
| 02/07/26 | US$528.10 | +2.67% | 221,894 |
| 01/07/26 | US$514.39 | -4.20% | 303,751 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
